CHAQ Chardan Healthcare Acquisition 2 Corp.

Chardan Healthcare Acquisition 2 Corp. operates as a blank check company. The company was founded in June 2018 and is headquartered in New York, NY.

On 3/23/2021 the company announced a pending merger with Renovacor, Inc., an early-stage biotechnology company developing AAV-based gene therapies for devastating cardiovascular and central nervous system (CNS) diseases resulting from BAG3 gene dysfunction.  

$9.94  -0.06 (-0.60%)
As of 06/21/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  06/18/2020
Outstanding shares:  10,778,305
Average volume:  5,868
Market cap:   $107,244,135
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   -20.08
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy